Two-Year Results from Onyx ONE Trial: No Difference Between Onyx DES and BioFreedom DCS

The results, consistent with the outcomes seen at one year, showed that at two years there were no differences between HBR patients on one month of DAPT who received the Onyx permanent polymer drug-eluting stent (DES), made by Medtronic, and those who received the BioFreedom polymer-free drug-coated stent (DCS), made by Biosensors.

Source: News from Angioplasty.Org - June 9, 2022 Category: Cardiology Source Type: news